Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials-Reference-Cited by-同舟云学术

Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials

Published:2018-06 Issue:6 Volume:24 Page:1274-1280
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Pasquini Marcelo C.,Logan Brent,Jones Richard J.,Alousi Amin M.,Appelbaum Frederick R.,Bolaños-Meade Javier,Flowers Mary E.D.,Giralt Sergio,Horowitz Mary M.,Jacobsohn David,Koreth John,Levine John E.,Luznik Leo,Maziarz Richard,Mendizabal Adam,Pavletic Steven,Perales Miguel-Angel,Porter David,Reshef Ran,Weisdorf Daniel,Antin Joseph H.

Funder

National Heart, Lung, and Blood Institute

National Cancer Institute

National Institute of Allergy and Infectious Diseases

Health Resources and Services Administration

Department of Health, Australian Government

U.S. Department of Health and Human Services

Miltenyi Biotec

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference27 articles.

1. Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303

2. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors;Nash;Blood,2000

3. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation;Ratanatharathorn;Blood,1998

4. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia;Storb;N Engl J Med,1986

5. Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia;Bacigalupo;Blood,1991

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haploidentical peripheral blood stem cell transplantation improves the survival of older patients with myeloid malignancies under low-dose antithymocyte globin (ATG)/post-cyclophosphamide (PTCy)-based regimen for graft-versus-host disease prophylaxis;2024-08-13

2. Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial;Blood Cancer Journal;2024-02-19

3. Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy;Cytotherapy;2024-02

4. Planning GvHD preemptive therapy: risk factors, biomarkers, and prognostic scores;Hematology;2023-12-08

5. Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention;Blood Advances;2023-08-11